- Home
- NBY vs SILO Comparison
NBY vs SILO Comparison
Compare NBY & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- SILO
- Stock Information
- Founded
- NBY 2000
- SILO 2010
- Country
- NBY United States
- SILO United States
- Employees
- NBY N/A
- SILO N/A
- Industry
- NBY
- SILO Apparel
- Sector
- NBY
- SILO Consumer Discretionary
- Exchange
- NBY Nasdaq
- SILO Nasdaq
- Market Cap
- NBY 3.8M
- SILO 4.5M
- IPO Year
- NBY 2007
- SILO N/A
- Fundamental
- Price
- NBY $0.61
- SILO $0.66
- Analyst Decision
- NBY Strong Buy
- SILO
- Analyst Count
- NBY 1
- SILO 0
- Target Price
- NBY $0.85
- SILO N/A
- AVG Volume (30 Days)
- NBY 43.7K
- SILO 537.0K
- Earning Date
- NBY 08-14-2025
- SILO 08-13-2025
- Dividend Yield
- NBY N/A
- SILO N/A
- EPS Growth
- NBY N/A
- SILO N/A
- EPS
- NBY 0.41
- SILO N/A
- Revenue
- NBY $9,781,000.00
- SILO $72,102.00
- Revenue This Year
- NBY $23.91
- SILO $1.86
- Revenue Next Year
- NBY $32.05
- SILO N/A
- P/E Ratio
- NBY $1.56
- SILO N/A
- Revenue Growth
- NBY 113.47
- SILO N/A
- 52 Week Low
- NBY $0.44
- SILO $0.41
- 52 Week High
- NBY $1.01
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- NBY 48.11
- SILO 49.10
- Support Level
- NBY $0.54
- SILO $0.56
- Resistance Level
- NBY $0.65
- SILO $0.73
- Average True Range (ATR)
- NBY 0.04
- SILO 0.07
- MACD
- NBY 0.00
- SILO -0.00
- Stochastic Oscillator
- NBY 41.19
- SILO 43.67
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.